chrX-17687730-C-CT
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP6_Very_Strong
The NM_001291867.2(NHS):c.566-10dupT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 1.0 ( 38910 hom., 33276 hem., cov: 0)
Exomes 𝑓: 1.0 ( 367310 hom. 363551 hem. )
Failed GnomAD Quality Control
Consequence
NHS
NM_001291867.2 intron
NM_001291867.2 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.232
Publications
4 publications found
Genes affected
NHS (HGNC:7820): (NHS actin remodeling regulator) This gene encodes a protein containing four conserved nuclear localization signals. The encoded protein functions in eye, tooth, craniofacial and brain development, and it can regulate actin remodeling and cell morphology. Mutations in this gene have been shown to cause Nance-Horan syndrome, and also X-linked cataract-40. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2014]
NHS Gene-Disease associations (from GenCC):
- Nance-Horan syndromeInheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- early-onset nuclear cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP6
Variant X-17687730-C-CT is Benign according to our data. Variant chrX-17687730-C-CT is described in ClinVar as [Likely_benign]. Clinvar id is 96644.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 1.00 AC: 111054AN: 111069Hom.: 38915 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
111054
AN:
111069
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 1.00 AC: 183366AN: 183374 AF XY: 1.00 show subpopulations
GnomAD2 exomes
AF:
AC:
183366
AN:
183374
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: InbreedingCoeff AF: 1.00 AC: 1098182AN: 1098197Hom.: 367310 Cov.: 34 AF XY: 1.00 AC XY: 363551AN XY: 363555 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
1098182
AN:
1098197
Hom.:
Cov.:
34
AF XY:
AC XY:
363551
AN XY:
363555
show subpopulations
African (AFR)
AF:
AC:
26396
AN:
26402
American (AMR)
AF:
AC:
35204
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
AC:
19386
AN:
19386
East Asian (EAS)
AF:
AC:
30204
AN:
30204
South Asian (SAS)
AF:
AC:
54147
AN:
54148
European-Finnish (FIN)
AF:
AC:
40533
AN:
40533
Middle Eastern (MID)
AF:
AC:
4136
AN:
4136
European-Non Finnish (NFE)
AF:
AC:
842084
AN:
842087
Other (OTH)
AF:
AC:
46092
AN:
46094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.543
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Data not reliable, filtered out with message: InbreedingCoeff AF: 1.00 AC: 111107AN: 111122Hom.: 38910 Cov.: 0 AF XY: 1.00 AC XY: 33276AN XY: 33280 show subpopulations
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
111107
AN:
111122
Hom.:
Cov.:
0
AF XY:
AC XY:
33276
AN XY:
33280
show subpopulations
African (AFR)
AF:
AC:
30520
AN:
30531
American (AMR)
AF:
AC:
10469
AN:
10472
Ashkenazi Jewish (ASJ)
AF:
AC:
2641
AN:
2641
East Asian (EAS)
AF:
AC:
3501
AN:
3501
South Asian (SAS)
AF:
AC:
2567
AN:
2567
European-Finnish (FIN)
AF:
AC:
5960
AN:
5960
Middle Eastern (MID)
AF:
AC:
219
AN:
219
European-Non Finnish (NFE)
AF:
AC:
53036
AN:
53036
Other (OTH)
AF:
AC:
1511
AN:
1512
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.534
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2522
AN:
2522
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Jul 12, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 21, 2016
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nance-Horan syndrome Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Jan 06, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Cataract 40 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nance-Horan syndrome;C4049004:Cataract 40 Benign:1
Apr 25, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.